Showing 17,081 - 17,100 results of 100,618 for search '(( 59 nn decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.54s Refine Results
  1. 17081
  2. 17082
  3. 17083

    Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2′-Deoxycytidine Results in Increased Tumorigenicity by Christopher A. Hamm (255816)

    Published 2009
    “…To examine its effect on tumorigenesis, we induced DNA demethylation in a rat model of human chondrosarcoma using 5-aza-2-deoxycytidine. …”
  4. 17084
  5. 17085
  6. 17086
  7. 17087
  8. 17088

    Encapsulation studies with 5(6)-Carboxyfluorescein. by Sushanth Gudlur (307116)

    Published 2013
    “…<p>(A) 5(6)-Carboxyfluorescein loaded peptide vesicles were prepared in different ethanol concentrations and separated over 30 kDa MWCO filters. …”
  9. 17089

    Ultrafast Light-Driven Nanomotors Based on an Acridane Stator by Artem A. Kulago (2320765)

    Published 2010
    “…The introduction of a cyclopentanylidene rotor unit results in a decrease in steric hindrance with respect to the stator, and as a consequence, a 10<sup>12</sup>-fold increase in the rate of thermal helix inversion is observed. …”
  10. 17090
  11. 17091
  12. 17092
  13. 17093
  14. 17094
  15. 17095
  16. 17096
  17. 17097
  18. 17098
  19. 17099

    DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”
  20. 17100

    DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”